Insilico rounds out C-suite as it readies for clinic, U.S. growth

The addition of BD veteran Michelle Chen as CBO completes Insilico’s executive team and readies the AI company to expand in the U.S. and Europe, four months after raising a $255 million series C round.

Chen’s hiring follows that of acting CMO Robert Spiegel and CFO Nirav Jhaveri in September, and gives the company a seasoned dealmaker who honed her BD chops at BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Merck & Co. Inc. (NYSE:MRK), Roche (SIX:ROG; OTCQX:RHHBY) and WuXi Biologics Inc. (HKEX:2269)...